Eric Ureno
About Eric Ureno
Eric Ureno is a Senior Research Associate specializing in Mass Spectrometry at Cytomx Therapeutics, with extensive experience in method development for complex biologics and analytical development for drug programs.
Work at CytomX Therapeutics
Eric Ureno has been employed at CytomX Therapeutics as a Senior Research Associate in Mass Spectrometry since 2019. In this role, he leads analytical development for both internal programs and partnered collaborations. He supports various functions in drug development, including upstream, downstream, formulation, research, and clinical stages. His expertise in mass spectrometry is utilized for molecule evaluation, characterization, and critical quality attribute assessment.
Education and Expertise
Eric Ureno holds a Bachelor of Science degree in Biochemistry from Cal State East Bay, which he completed from 2007 to 2011. He furthered his education by obtaining a Master of Science degree in Biochemistry and Chemistry from the same institution, studying from 2012 to 2015. His expertise includes method development for complex biologics, such as antibody/Probody, ADC/PDC, and bispecific molecules. He also manages contract manufacturing organization activities, including method tech transfer and qualification.
Background in Biologics and Mass Spectrometry
Eric Ureno has a diverse background in the biotechnology field, having worked in various roles related to protein analytics and quality control. He began his career as a Production Technician at Biolog, Inc. in 2012. He then served as a Process Development Associate I at Perseid Therapeutics, focusing on protein analytics. He also worked as a QA and QC Analyst at Bayer Healthcare in Germany. His cumulative experience has equipped him with a strong foundation in mass spectrometry and biologics.
Professional Experience Prior to CytomX Therapeutics
Before joining CytomX Therapeutics, Eric Ureno gained valuable experience in the biotechnology sector. He worked at Prozyme, Inc. as a Production Associate from 2010 to 2011 and held a position at Perseid Therapeutics as a Process Development Associate I from 2012 to 2013. His role at Bayer Healthcare as a QA and QC Analyst from 2014 to 2015 further developed his skills in quality assurance and control within the pharmaceutical industry.